Large-scale testing (Phase 3)Study completedNCT02132169
What this trial is testing
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
Who this might be right for
Atopic Disease (Including Allergic Conjunctivitis)
Aciex Therapeutics, Inc. 512